Amarantus Bioscience Holdings Inc (OTC Pink - Current Information:AMBS)

0.0471
Delayed Data
As of May 01
 +0.0002 / +0.43%
Today’s Change
0.03
Today|||52-Week Range
0.20
-42.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$49.1M

Company Description

Amarantus Bioscience Holdings, Inc. is a development stage biotechnology company, which engages in discovering and developing treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. It develops and owns intellectual property and proprietary technology to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
953 Indiana Street
San Francisco California 94107
P:(408) 737-2734
Investor Relations:
14087372734101

Employees

Shareholders

Individual stakeholders5.14%
Mutual fund holders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Elise BrownellSenior VP-Operations & Program Management
Robert Edward FarrellChief Financial Officer
John W. CommissiongDirector & Chief Scientific Officer
F. Randall GrimesHead-Sponsored Research

To view my watchlist

Not a member yet?

Sign up now for a free account